HOME    CONTACT    DISCLAIMER    SEARCH   
Home
About Us

Cilian AG is an innovative biotechnology enterprise, which uses the unique abilities of Ciliates, a new class of production organisms, for the industrial production of therapeutic proteins.

» More
 
CIPEX-System

Cilian AG demonstrates the broad applicability of the ciliate based expression system (CIPEX-system) within the frame of feasibility- and evaluation studies by the heterologous expression of a total of 13 pharmaceutically relevant proteins.

» More
 
Product

Ciliates of the genus Tetrahymena naturally secrete large quantities of enzymes, so-called lysosomal acid hydrolases, into the surrounding culture medium.

» More
News

10.10.2011
Press release
"Cilian AG reached major milestone with the production and in vivo testing of recombinant flu viral protein as potential vaccine against Influenza"
» more

10.08.2011
Press release
"Cilian AG granted two European Patents for Ciliate based..."
» more

22.02.2011
BMC Biotechnology
"Cilian publishes article in BMC Biotechnology ..."
» more

institutional member of BioMed Central